Health Katherine Harmon Courage Racism leads to troubled sleep — and it’s putting Black Americans’ heart health at risk
Health Usha Lee McFarling Brains of Black Americans age faster, study finds, with racial stressors a likely factor
Health Karen Weintraub Her son died. Two decades later, she met the medical student who got his heart
Health Ruth Hailu Patients whose blood pressure only spikes at the doctor’s office are twice as likely to die of a heart attack or other cardiac event
First Opinion Larry Husten Beware the hype over the Apple Watch heart app. The device could do more harm than good
Exclusive Ivan Oransky and Adam Marcus Harvard and the Brigham call for more than 30 retractions of cardiac stem cell research
Pharma Matthew Herper STAT Plus: Esperion Therapeutics’ statin alternative reduces heart attack risk. Is that enough to save the company?
Health Matthew Herper One type of artificial sweetener may increase heart attack risk, preliminary study says
Health Tech Lizzy Lawrence STAT Plus: A device restored hand movement for two stroke survivors. Researchers want to take it mainstream
First Opinion Nisha Parikh and Alison Cowan Pregnancy complications heighten heart risks in later life. It’s time to pay attention
Health Katherine Harmon Courage A simple screening question could help millions of women prevent cardiovascular disease. Why aren’t we using it?
Biotech Damian Garde STAT Plus: Data show strong results for Alnylam therapy for heart disease, but magnitude of benefit will stir debate
Health Tech Mario Aguilar STAT Plus: An ambitious stroke prevention study tests the Apple Watch’s promise in health
Health Katherine Gilyard Study: religious practice, spirituality can improve Black Americans’ cardiovascular health
In the Lab Elizabeth Cooney New research digs into the genetic drivers of heart failure, with an eye to precision treatments
Biotech Damian Garde STAT Plus: Alnylam therapy for increasingly common heart disease succeeds in closely watched trial
The Readout LOUD Damian Garde and Adam Feuerstein Listen: CRISPR for the heart, biotech’s recovery, & what it means to be a ‘hot girl’
Biotech Matthew Herper and Megan Molteni STAT Plus: Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease
Biotech Matthew Herper STAT Plus: New analysis of Amarin’s Vascepa resurrects big questions about effectiveness
Health Akila Muthukumar STAT Plus: Popular drug may have new benefit in men with diabetes, but not women, study shows
Pharmalot Ed Silverman STAT Plus: High blood pressure pills are costly — but also hard to find — in some lower-income countries
Matt's Take Matthew Herper STAT Plus: Robert Califf is a fervent believer in data. At the FDA, will that be enough?
Special Report Damian Garde STAT Plus: It’s the cardiovascular version of Alzheimer’s — and, for a biotech with a promising drug, it could be a windfall
Health Elizabeth Cooney ‘Information alone is not enough’: New Jackson Heart Study leader commits to putting research into action
Health Tech Mario Aguilar STAT Plus: With Apple’s backing, can an app help heart attack patients navigate recovery?
In the Lab Megan Molteni STAT Plus: Gene therapy to regenerate cardiac muscle after a heart attack passes a key test in pigs
First Opinion Cynthia A. Stuenkel and JoAnn E. Manson Are five decades of progress in women’s health in peril?